Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-056793
Filing Date
2020-12-11
Accepted
2020-12-11 07:30:59
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glto-10q_20200930.htm 10-Q 2236400
2 EX-31.1 glto-ex311_8.htm EX-31.1 23705
3 EX-31.2 glto-ex312_6.htm EX-31.2 23565
4 EX-32.1 glto-ex321_9.htm EX-32.1 16424
  Complete submission text file 0001564590-20-056793.txt   5838069

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glto-20200930.xml EX-101.INS 888188
6 XBRL TAXONOMY EXTENSION SCHEMA glto-20200930.xsd EX-101.SCH 41105
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glto-20200930_cal.xml EX-101.CAL 35530
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glto-20200930_def.xml EX-101.DEF 172214
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glto-20200930_lab.xml EX-101.LAB 341012
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glto-20200930_pre.xml EX-101.PRE 278651
Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39655 | Film No.: 201382246
SIC: 2834 Pharmaceutical Preparations